Table 1. Indications for living donor liver transplantation in the USA.
Low MELD + complications of cirrhosis |
HCC outside tumor criteria with favorable tumor biology |
HCC within tumor criteria in regions with long (>1 year) wait |
Low MELD + cirrhosis + significantly decreased quality of life |
Low MELD + cholestatic liver disease with recurrent cholangitis |
MELD, model for end-stage liver disease; HCC, hepatocellular carcinoma.